Dr. Fred R. Hirsch Departs IASLC CEO Role, Joins Mount Sinai...

Fred R. Hirsch, MD, resigned from his position of IASLC CEO at the end of October and has joined Mount Sinai Hospital in New...

Prophylactic Cranial Irradiation in Locally Advanced NSCLC Falls Flat

By John Armstrong, MD, FRCPI, DABR, FFRRCSI RTOG 0214, a phase III randomized trial, is the biggest trial to date testing prophylactic cranial irradiation (PCI)...

Advocacy & Survivorship

- Advertisement -

Meeting News

Scientific Highlights from the IASLC Latin America Conference on Lung Cancer

By Edgardo S. Santos Castillero, MD, FACP Five abstracts were presented at the Presidential Symposium of the 2018 IASLC Latin America Conference on Lung Cancer,...